132 related articles for article (PubMed ID: 23916779)
1. Comparison of pre-hospital 600 mg or 900 mg vs. peri-interventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial.
Ducci K; Grotti S; Falsini G; Angioli P; Liistro F; Mandò M; Porto I; Bolognese L
Int J Cardiol; 2013 Oct; 168(5):4814-6. PubMed ID: 23916779
[No Abstract] [Full Text] [Related]
2. Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction.
Beigel R; Fefer P; Rosenberg N; Novikov I; Elian D; Fink N; Segev A; Guetta V; Hod H; Matetzky S
Am J Cardiol; 2013 Nov; 112(10):1551-6. PubMed ID: 23972349
[TBL] [Abstract][Full Text] [Related]
3. Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Kim JY; Jeong MH; Moon JH; Ahn YK; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae IH; Cho MC; Jang YS; Yoon JH; Seung KB; Park SJ;
Am J Cardiol; 2012 Dec; 110(11):1598-606. PubMed ID: 22935526
[TBL] [Abstract][Full Text] [Related]
4. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
Patti G; Bárczi G; Orlic D; Mangiacapra F; Colonna G; Pasceri V; Barbato E; Merkely B; Edes I; Ostojic M; Wijns W; Di Sciascio G
J Am Coll Cardiol; 2011 Oct; 58(15):1592-9. PubMed ID: 21958886
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
Mangiacapra F; Muller O; Ntalianis A; Trana C; Heyndrickx GR; Bartunek J; Vanderheyden M; Wijns W; De Bruyne B; Barbato E
Am J Cardiol; 2010 Nov; 106(9):1208-11. PubMed ID: 21029814
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of pretreatment with high-dose clopidogrel in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
Fefer P; Hod H; Hammerman H; Segev A; Beinart R; Boyko V; Behar S; Matetzky S
Am J Cardiol; 2009 Aug; 104(4):514-8. PubMed ID: 19660604
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary intervention.
Larson DM; Duval S; Sharkey SS; Solie C; Tschautscher C; Lips DL; Burke MN; Steinhubl S; Henry TD
Am Heart J; 2010 Jul; 160(1):202-7. PubMed ID: 20598993
[TBL] [Abstract][Full Text] [Related]
8. Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
ten Berg JM; van 't Hof AW; Dill T; Heestermans T; van Werkum JW; Mosterd A; van Houwelingen G; Koopmans PC; Stella PR; Boersma E; Hamm C;
J Am Coll Cardiol; 2010 Jun; 55(22):2446-55. PubMed ID: 20510211
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 600 versus 300-mg clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.
Lin GM; Li YH
Am J Cardiol; 2011 Feb; 107(4):641. PubMed ID: 21295179
[No Abstract] [Full Text] [Related]
10. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
Di Sciascio G; Patti G; Pasceri V; Gatto L; Colonna G; Montinaro A;
J Am Coll Cardiol; 2010 Aug; 56(7):550-7. PubMed ID: 20688209
[TBL] [Abstract][Full Text] [Related]
11. Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
Choi CU; Rha SW; Oh DJ; Poddar KL; Na JO; Kim JW; Lim HE; Kim EJ; Park CG; Seo HS; Hong TJ; Park JS; Kim YJ; Hur SH; Seong IW; Chae JK; Cho MC; Bae JH; Choi DH; Jang YS; Chae IH; Kim HS; Kim CJ; Yoon JH; Ahn TH; Tahk SJ; Chung WS; Seung KB; Chae SC; Park SJ; Ahn YK; Jeong MH
Am Heart J; 2011 Feb; 161(2):373-382.e1-3. PubMed ID: 21315222
[TBL] [Abstract][Full Text] [Related]
12. One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
Ndrepepa G; Kastrati A; Mehilli J; Neumann FJ; ten Berg J; Bruskina O; Dotzer F; Seyfarth M; Pache J; Dirschinger J; Berger PB; Schömig A
Eur Heart J; 2008 Feb; 29(4):455-61. PubMed ID: 18158289
[TBL] [Abstract][Full Text] [Related]
13. Clopidogrel pre-treatment is associated with reduced in-hospital mortality in primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
Dörler J; Edlinger M; Alber HF; Altenberger J; Benzer W; Grimm G; Huber K; Pachinger O; Schuchlenz H; Siostrzonek P; Zenker G; Weidinger F;
Eur Heart J; 2011 Dec; 32(23):2954-61. PubMed ID: 21920970
[TBL] [Abstract][Full Text] [Related]
14. Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study.
El Khoury C; Dubien PY; Mercier C; Belle L; Debaty G; Capel O; Perret T; Savary D; Serre P; Bonnefoy E;
Arch Cardiovasc Dis; 2010 May; 103(5):285-92. PubMed ID: 20619238
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.
Feldman DN; Fakorede F; Minutello RM; Bergman G; Moussa I; Wong SC
Am J Cardiol; 2010 Feb; 105(3):323-32. PubMed ID: 20102943
[TBL] [Abstract][Full Text] [Related]
16. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
17. Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Kohli P; Udell JA; Murphy SA; Cannon CP; Antman EM; Braunwald E; Wiviott SD
J Am Coll Cardiol; 2014 Jan; 63(3):225-32. PubMed ID: 24140678
[TBL] [Abstract][Full Text] [Related]
18. Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry.
Lin GM; Li YH; Chu KM; Han CL
Am Heart J; 2011 Jul; 162(1):e17. PubMed ID: 21742077
[No Abstract] [Full Text] [Related]
19. Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study.
Mangiacapra F; Patti G; Barbato E; Orlic D; Peace AJ; D'Ambrosio A; Ostojic M; Wijns W; Di Sciascio G
Int J Cardiol; 2012 Oct; 160(3):213-4. PubMed ID: 22727961
[No Abstract] [Full Text] [Related]
20. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Carvajal J; Lehmann A; Lambert M; Bonnet JL; Alessi MC
J Am Coll Cardiol; 2006 Oct; 48(7):1339-45. PubMed ID: 17010792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
